Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 7 Rectal Neoplasms 3 Colorectal Neoplasms 3 Colonic Neoplasms 3 Stomach Neoplasms 2 Neoplasm, Residual 2 Mesothelioma, Malignant 2 Uterine Cervical Neoplasms 1 Turcot syndrome 1 Solitary Fibrous Tumor, Pleural 1 Sarcopenia 1 Sarcoglycanopathies 1 Prostatic Neoplasms 1 Peritoneal Neoplasms 1 Pancreatic Neuroendocrine Tumors (pNET) 1 Pancreatic Neoplasms 1 Nasopharyngeal Carcinoma 1 NSCLC 1 Microsatellite Instability 1 Mesothelioma 1 Melanoma 1 Malnutrition 1 Lung Neoplasms 1 HER2 Negative Breast Cancer 1 Glioblastoma 1 Gastrointestinal Neoplasms 1 Frailty 1 Esophageal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Biliary Tract Neoplasms 1

Interventions

ribociclib 1 Tretinoin 1 Letrozole 1 Goserelin 1 Drug Therapy 1 Chemotherapy, Adjuvant 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

HER2 Negative Breast Cancer × Chemotherapy, Adjuvant × 1 year × Clear all

NCT06953882 2026-05-26

SELECT

Yale University

Phase 2 Recruiting

HER2 Negative Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡